Ah Ram Chang
Papers
1
Total Citations
22
H-Index
1
About
Ah Ram Chang is a leading radiation oncologist whose research focuses on stereotactic body radiotherapy (SBRT) for prostate cancer, with particular emphasis on treatment outcomes and prostate-specific antigen (PSA) kinetics. Her most cited work, a multicenter retrospective study published in 2018 as part of the Korean Radiation Oncology Group (KROG 15-01), has garnered 22 citations and provides critical long-term data on robotic SBRT efficacy across three academic hospitals in Korea. This landmark study established benchmarks for PSA response patterns and treatment durability, directly informing clinical protocols for localized prostate cancer management. Dr. Chang’s contributions are especially significant for advancing non-invasive radiotherapy alternatives, offering patients reduced treatment schedules without compromising oncological control. Her research bridges the gap between technical innovation and real-world clinical application, making her a key figure in Asian radiation oncology. By systematically analyzing PSA kinetics, she has helped refine patient selection criteria and follow-up strategies, ultimately improving quality of life for prostate cancer survivors. Her work continues to shape evidence-based guidelines for SBRT adoption in Korea and beyond.
Research Focus
Key Achievements
Top Papers
- 1